BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
IL1A
,
Apoptosis
,
Hepatitis
,
Stem cell
,
Early pregnancy factor
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
VEGFR- 1
Summary
General Info
Curated Studies
Most Correlated Studies
HUVECs treated with doxorubicin (topoisomerase-2 inhibitor) or with axitinib (VEGFRs inhibitor)
Glioma cell lines U-138MG and LN-308 depleted of VEGFR-2
Embryonic stem cells expressing CD144, CD41, VEGFR during endothelial differentiation
Pulmonary Hypertension in a Rodent Model 1
Breast tumors after addition of multikinase inhibitor sorafenib to existing endocrine therapy
Explore Curated Studies Results
Literature
Most Relevant Literature
Interaction of Some Amino-Nitrile Derivatives with Vascular Endothelial Growth Factor Receptor 1 (VE…
Vascular Endothelial Growth Factor Receptor 1 Targeting Fusion Polypeptides with Stimuli-Responsiven…
Immunohistochemical expression of VEGFR1 in non small cell lung carcinomas: Lower VEGFR1 expression …
Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A …
Conjugation of VEGFR1/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and ant…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma
Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Advers…
A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cance…
A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Ki…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ